يعرض 1 - 18 نتائج من 18 نتيجة بحث عن '"Roel J.W. van Kampen"', وقت الاستعلام: 0.73s تنقيح النتائج
  1. 1
    Academic Journal
  2. 2
  3. 3
    Academic Journal
  4. 4
  5. 5

    المساهمون: UCL - (SLuc) Centre du cancer, UCL - SSS/IREC/SLUC - Pôle St.-Luc, UCL - (SLuc) Service d'hématologie, Internal medicine, Hematology, CCA - Cancer Treatment and quality of life

    المصدر: Journal of clinical oncology, Vol. 39, no. 25, p. 2758-2767 (2021)
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 39(25), 2758-2767. American Society of Clinical Oncology
    Stege, C A M, Nasserinejad, K, van der Spek, E, Bilgin, Y M, Kentos, A, Sohne, M, van Kampen, R J W, Ludwig, I, Thielen, N, Durdu-Rayman, N, de Graauw, N C H P, van de Donk, N W C J, de Waal, E G M, Vekemans, M C, Timmers, G J, van der Klift, M, Soechit, S, Geerts, P A F, Silbermann, M H, Oosterveld, M, Nijhof, I S, Sonneveld, P, Klein, S K, Levin, M D & Zweegman, S 2021, ' Ixazomib, Daratumumab, and Low-Dose Dexamethasone in Frail Patients With Newly Diagnosed Multiple Myeloma : The Hovon 143 Study ', Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 39, no. 25, pp. 2758-2767 . https://doi.org/10.1200/JCO.20.03143

  6. 6
  7. 7
  8. 8

    المساهمون: RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, MUMC+: MA Med Staf Artsass Interne Geneeskunde (9), RS: CAPHRI - R2 - Creating Value-Based Health Care, MUMC+: KIO Kemta (9), Interne Geneeskunde, MUMC+: MA Medische Oncologie (9), Epidemiologie, RS: CAPHRI - R5 - Optimising Patient Care, Health Services Research

    المصدر: Oncotarget
    Oncotarget, 8(45), 79223-79233. Impact Journals LLC

  9. 9

    المساهمون: RS: CAPHRI - R2 - Creating Value-Based Health Care, RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, MUMC+: MA Med Staf Artsass Interne Geneeskunde (9), Interne Geneeskunde, MUMC+: MA Medische Oncologie (9), Health Services Research, MUMC+: KIO Kemta (9), RS: CAPHRI - R5 - Optimising Patient Care, Epidemiologie

    المصدر: Oncologist, 21(5), 555-562. AlphaMed Press
    Oncologist, 21, 555-62
    Oncologist, 21, 5, pp. 555-62

  10. 10

    المساهمون: RS: CAPHRI School for Public Health and Primary Care, Pathologie, RS: CAPHRI - R2 - Creating Value-Based Health Care, RS: CAPHRI - R5 - Optimising Patient Care, RS: GROW - Oncology, Interne Geneeskunde, Algemene Heelkunde, Health Services Research, MUMC+: KIO Kemta (9), Epidemiologie, RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy

    المصدر: Oncologist, 20, 8, pp. 856-63
    Oncologist, 20(8), 856-863. AlphaMed Press
    Oncologist, 20, 856-63

  11. 11

    المساهمون: Kenniscentrum ACHIEVE, RS: CAPHRI - R5 - Optimising Patient Care, RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Promovendi ODB, RS: CAPHRI - R6 - Promoting Health & Personalised Care, Family Medicine, Interne Geneeskunde, MUMC+: MA Medische Oncologie (9)

    المصدر: Journal of geriatric oncology, 8(3), 176-184. Elsevier
    Journal of Geriatric Oncology, 8(3), 176-184. Elsevier

    وصف الملف: application/pdf; Print-Electronic

  12. 12

    المساهمون: AGEM - Amsterdam Gastroenterology Endocrinology Metabolism, Laboratory Genetic Metabolic Diseases, CCA -Cancer Center Amsterdam, AII - Infectious diseases, Human Genetics, APH - Quality of Care, ANS - Amsterdam Neuroscience, RS: CAPHRI other, Interne Geneeskunde, MUMC+: MA Medische Oncologie (9)

    المصدر: BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 1863(3), 721-730. Elsevier
    Biochimica et Biophysica Acta-Molecular Basis of Disease, 1863(3), 721-730. Elsevier Science
    van Kuilenburg, A B P, Meijer, J, Maurer, D, Dobritzsch, D, Meinsma, R, Los, M, Knegt, L C, Zoetekouw, L, Jansen, R L H, Dezentjé, V, van Huis-Tanja, L H, van Kampen, R J W, Hertz, J M & Hennekam, R C M 2017, ' Severe fluoropyrimidine toxicity due to novel and rare DPYD missense mutations, deletion and genomic amplification affecting DPD activity and mRNA splicing ', BBA Molecular Basis of Disease, vol. 1863, no. 3, pp. 721-730 . https://doi.org/10.1016/j.bbadis.2016.12.010

  13. 13

    المساهمون: RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, MUMC+: MA Med Staf Artsass Interne Geneeskunde (9), Promovendi ODB, Interne Geneeskunde, Epidemiologie, RS: CAPHRI - R5 - Optimising Patient Care, MUMC+: MA Medische Oncologie (9)

    المصدر: Oncotarget, 7(20), 29412-29419. Impact Journals LLC
    Oncotarget

  14. 14

    المساهمون: Health Services Research, Interne Geneeskunde, MUMC+: KIO Kemta (9), RS: CAPHRI School for Public Health and Primary Care, RS: GROW - School for Oncology and Reproduction

    المصدر: Value in Health, 14(5), 777-784. Elsevier Science

  15. 15

    المساهمون: Epidemiologie, MUMC+: MA Medische Oncologie (9), Interne Geneeskunde, RS: GROW - School for Oncology and Reproduction

    المصدر: Breast Cancer Research and Treatment, 141, 3, pp. 507-14
    Breast Cancer Research and Treatment, 141(3), 507-514. Springer, Cham
    Breast Cancer Research and Treatment, 141, 507-14

  16. 16

    المساهمون: Hematology, CCA - Innovative therapy, Interne Geneeskunde, RS: GROW - School for Oncology and Reproduction

    المصدر: JOURNAL OF CLINICAL ONCOLOGY
    r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
    instname
    Journal of Clinical Oncology, 29(10), 1342-1348. American Society of Clinical Oncology
    van Kampen, R J W, Canals, C, Schouten, H C, Nagler, A, Thomson, K J, Vernant, J P, Buzyn, A, Boogaerts, M A, Luan, J J, Maury, S, Milpied, N J, Jouet, J P, Ossenkoppele, G J & Sureda, A 2011, ' Allogeneic Stem-Cell Transplantation As Salvage Therapy for Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma Relapsing After an Autologous Stem-Cell Transplantation: An Analysis of the European Group for Blood and Marrow Transplantation Registry ', Journal of Clinical Oncology, vol. 29, no. 10, pp. 1342-1348 . https://doi.org/10.1200/JCO.2010.30.2596

  17. 17
  18. 18